Adamas Pharmaceuticals, Inc. ADMS
8.22 +8.22
Day range unavailable
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2020 · select a line to chart its full history
Income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 74.46M | 54.64M | 34.05M | 571.00K | 572.00K | |
| 72.42M | 52.17M | 33.41M | 554.00K | 572.00K | |
| -44.16M | -92.23M | -115.02M | -87.93M | -60.98M | |
| -57.40M | -105.19M | -131.00M | -89.49M | -60.06M | |
| -2.03 | -3.80 | -4.87 | -3.97 | -2.77 |
Balance sheet
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 71.66M | 65.77M | 56.60M | 91.32M | 23.73M | |
| 120.03M | 162.16M | 234.81M | 186.18M | 142.47M | |
| 170.00M | 163.05M | 144.93M | 120.05M | 10.29M | |
| 136.42M | 135.99M | 119.12M | 102.65M | 0 | |
| -49.98M | -893.00K | 89.89M | 66.13M | 132.18M |
Cash flow
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| -50.71M | -80.78M | -104.22M | -66.83M | -48.07M | |
| 54.94M | 88.86M | -69.34M | 25.57M | -26.71M | |
| 1.65M | 1.08M | 138.85M | 108.84M | 65.41M | |
| 5.89M | 9.17M | -34.71M | 67.58M | -9.37M |